The overexpression of DTX3L enhances proliferation, metastasis, and chemo-resistance of prostate cancer cells by repressing the transcription of IRF-1 and influencing phosphorylation of STAT1 (Bachmann et al., 2014). Here, STAT1 is linked to prostate carcinoma.